🇫🇷 SAN.PA — Sanofi

Healthcare Compra
← Volver

Precio actual

75,69 EUR

Máx. histórico

110,88

546 días

Caída desde máximo

-31,74%

Rango 52 semanas

71,25 – 91,15

Variación hoy

-0,75%

Cierre anterior

76,26

Rango de hoy

75,22 – 76,19

Volumen hoy

910.041

Información
Nombre completo
Sanofi
Divisa
EUR
Mercado
Paris
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
74.846
PER ⓘ
23,36 (puede no estar actualizado)
Dividend yield
5,40% (puede no estar actualizado)
Precio objetivo analistas
94,28 EUR (puede no estar actualizado)
Primera cotización
03/01/2000
Precio actualizado
hace 7 horas
Sobre la empresa

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases neurology, oncology, and other vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines that includes hepatitis A, typhoid, yellow fever, and rabies vaccines. It has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for treatment of alpha-synucleinopathies; and Innate Pharma SA for cell engager program targeting B7-H3. Further, it has a collaboration agreements with Atomwise to use ATOMNET platform and Insilico Medicine to use Pharma.AI, a medicine's AI platform; Kymera Therapeutics, Inc. to develop and commercialize protein degrader therapies targeting IRAK4 in patients with immune-inflammatory diseases; Nurix Therapeutics, Inc. to develop protein degradation therapies; Denali Therapeutics Inc. to treat systemic inflammatory diseases, such as ulcerative colitis; and Adagene Inc. for development of antibody-based therapies. Additionally, it has a collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; Teva Pharmaceuticals to co-develop and co-commercialize TEV'574, for treatment of ulcerative colitis and Crohn's disease; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Dividendos repartidos Total últimos 12 meses: 4,1200 EUR · Yield: 5,44%
Fecha de pago Importe por participación
05/05/2026 4,1200 EUR
12/05/2025 3,9200 EUR
13/05/2024 3,7600 EUR
30/05/2023 3,5600 EUR
06/05/2022 3,3300 EUR
05/05/2021 3,2000 EUR
04/05/2020 3,1500 EUR
09/05/2019 3,0700 EUR
11/05/2018 3,0300 EUR
16/05/2017 2,9600 EUR
10/05/2016 2,9300 EUR
11/05/2015 2,8500 EUR
12/05/2014 2,8000 EUR
09/05/2013 2,7700 EUR
10/05/2012 2,6500 EUR
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
12/03/2015 88,52 89,17 88,00 89,01 +0,26% 1,33% 2.688.142
11/03/2015 86,53 88,88 86,47 88,79 +3,35% 2,79% 3.794.409
10/03/2015 87,12 87,33 85,33 85,91 -1,39% 2,29% 2.889.381
09/03/2015 86,98 87,53 86,59 87,12 -0,06% 1,09% 2.362.537
06/03/2015 87,20 87,55 86,85 87,17 -0,22% 0,81% 2.541.449
05/03/2015 86,83 88,03 86,68 87,36 +0,45% 1,56% 2.802.846
04/03/2015 86,03 86,97 85,24 86,97 +1,50% 2,01% 3.157.785
03/03/2015 86,03 86,79 85,59 85,69 -0,28% 1,39% 2.565.157
02/03/2015 86,88 87,02 85,46 85,93 -1,48% 1,80% 3.216.121
27/02/2015 86,90 87,22 86,11 87,22 +0,18% 1,28% 3.914.113
26/02/2015 88,62 88,67 86,65 87,06 -1,75% 2,28% 4.078.912
25/02/2015 87,90 88,63 87,78 88,62 +0,39% 0,96% 2.630.391
24/02/2015 88,58 88,69 87,20 88,27 -0,34% 1,67% 2.415.953
23/02/2015 87,76 88,57 87,43 88,57 +1,90% 1,29% 2.711.324
20/02/2015 87,49 87,78 86,01 86,92 -0,51% 2,02% 4.972.157
19/02/2015 87,01 87,64 86,65 87,36 +1,30% 1,14% 3.418.612
18/02/2015 85,51 86,39 85,15 86,24 +1,38% 1,44% 2.443.916
17/02/2015 85,01 85,51 83,75 85,07 -0,22% 2,07% 2.500.886
16/02/2015 86,00 86,00 85,14 85,25 -1,16% 0,99% 1.536.815
13/02/2015 85,00 86,53 84,69 86,26 +2,13% 2,16% 3.322.040
12/02/2015 84,28 84,73 83,62 84,46 -0,09% 1,31% 3.103.309
11/02/2015 84,51 84,73 83,49 84,54 -0,32% 1,46% 2.074.805
10/02/2015 84,53 85,54 83,58 84,81 +0,53% 2,32% 2.996.779
09/02/2015 83,91 84,69 83,32 84,36 -0,21% 1,62% 3.968.937
06/02/2015 83,93 84,98 83,37 84,54 +0,56% 1,91% 4.360.606
05/02/2015 83,08 84,32 82,35 84,07 +3,60% 2,37% 4.546.416
04/02/2015 80,76 81,26 79,98 81,15 +0,10% 1,58% 3.982.306
03/02/2015 81,62 82,75 80,82 81,07 -0,68% 2,36% 3.650.442
02/02/2015 81,75 82,55 80,76 81,62 +0,09% 2,19% 2.925.695
30/01/2015 82,49 82,58 80,93 81,55 -0,32% 2,00% 3.897.546